HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Patrick A Singleton Selected Research

methylnaltrexone

8/2015The mu opioid receptor: A new target for cancer therapy?
4/2012Overexpression of the μ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis.
3/2011The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation.
8/2010Effect of perioperative opioids on cancer recurrence: a hypothesis.
6/2008Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Patrick A Singleton Research Topics

Disease

18Neoplasms (Cancer)
08/2015 - 10/2002
7Lung Neoplasms (Lung Cancer)
01/2015 - 09/2009
7Acute Lung Injury
07/2014 - 10/2007
7Lung Injury
03/2012 - 10/2007
4Breast Neoplasms (Breast Cancer)
08/2010 - 10/2002
3Neoplasm Metastasis (Metastasis)
01/2015 - 03/2011
3Pneumonia (Pneumonitis)
01/2011 - 12/2009
2Ventilator-Induced Lung Injury
07/2014 - 04/2009
2Hyperoxia
03/2012 - 12/2009
2Pulmonary Hypertension (Ayerza Syndrome)
08/2011 - 04/2008
2Sepsis (Septicemia)
12/2009 - 04/2005
2Inflammation
04/2009 - 10/2007
1Pain (Aches)
08/2015
1Constipation
08/2015
1Lymphoma (Lymphomas)
07/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2012
1Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
04/2012
1Chronic Obstructive Pulmonary Disease (COPD)
08/2011
1Lung Diseases (Lung Disease)
08/2011
1Asthma (Bronchial Asthma)
08/2011
1Lewis Lung Carcinoma
03/2011
1Vascular Diseases (Vascular Disease)
01/2011
1Respiratory Insufficiency (Respiratory Failure)
01/2011
1Prostatic Neoplasms (Prostate Cancer)
08/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2010
1Reperfusion Injury
12/2009
1Edema
04/2009
1Anoxia (Hypoxia)
04/2008
1Atherosclerosis
10/2007

Drug/Important Bio-Agent (IBA)

8Hyaluronic Acid (Hyaluronan)IBA
01/2015 - 10/2002
5methylnaltrexoneFDA Link
08/2015 - 06/2008
5Phosphotransferases (Kinase)IBA
08/2014 - 10/2002
4mu Opioid Receptors (mu Opioid Receptor)IBA
08/2015 - 06/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014 - 12/2009
4Opioid Receptors (Opioid Receptor)IBA
04/2012 - 08/2010
3Carrier Proteins (Binding Protein)IBA
01/2014 - 01/2011
3glucuronyl glucosamine glycan sulfate (Vessel)IBA
01/2013 - 10/2007
3Small Interfering RNA (siRNA)IBA
03/2011 - 12/2009
3Caveolin 1IBA
11/2010 - 04/2009
2Opioid Analgesics (Opioids)IBA
08/2015 - 08/2010
2nestin (nestin protein)IBA
01/2015 - 04/2012
2Serine Proteases (Serine Protease)IBA
01/2015 - 04/2005
2tyrosine receptor (receptor, tyrosine)IBA
08/2014 - 12/2009
2oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA
07/2014 - 04/2009
2Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2014 - 08/2011
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
11/2012 - 10/2010
2Myosin-Light-Chain KinaseIBA
03/2012 - 01/2011
2NADPH Oxidase (NAD(P)H oxidase)IBA
03/2012 - 12/2009
2Tyrosine (L-Tyrosine)FDA Link
03/2012 - 12/2009
24- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
03/2012 - 12/2009
2RNA (Ribonucleic Acid)IBA
01/2011 - 04/2008
2Proteins (Proteins, Gene)IBA
06/2010 - 12/2009
2Sirolimus (Rapamycin)FDA Link
06/2010 - 01/2010
2DNA (Deoxyribonucleic Acid)IBA
06/2010 - 09/2009
2rho-Associated KinasesIBA
06/2004 - 08/2003
1Narcotic Antagonists (Opioid Antagonists)IBA
08/2015
1CD44 AntigensIBA
01/2015
1Adenocarcinoma of lungIBA
01/2015
1Interleukin-6 (Interleukin 6)IBA
07/2014
1PaxillinIBA
07/2013
1IgA receptor (protein B)IBA
07/2013
1Cisplatin (Platino)FDA LinkGeneric
07/2013
1temsirolimusFDA Link
04/2012
1Superoxides (Superoxide)IBA
03/2012
1CortactinIBA
03/2012
1Cytoskeletal ProteinsIBA
03/2012
1EnzymesIBA
08/2011
1AgarIBA
03/2011
1Liposomes (Liposome)IBA
01/2011
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2011
1Lysosphingolipid ReceptorsIBA
10/2010
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2010
1SEW2871IBA
10/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2010
1Anesthetics (Anesthetic Agents)IBA
08/2010
1Morphine (MS Contin)FDA LinkGeneric
08/2010
1GTP Phosphohydrolases (GTPases)IBA
12/2009
1Dynamin IIIBA
12/2009
1N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA
12/2009
1Dynamins (Dynamin)IBA
12/2009
12-chloroethyl methyl sulfideIBA
12/2009
1Semaphorins (Semaphorin)IBA
09/2009
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
09/2009
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2009
1CytokinesIBA
05/2009
1bevacizumabFDA Link
06/2008
1Fluorouracil (Carac)FDA LinkGeneric
06/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2008
1SU 5416 (SU5416)IBA
04/2008
1sorafenib (BAY 43-9006)FDA Link
04/2008
1Dihydrotachysterol (AT 10)IBA
04/2008
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2008
1Protein CIBA
04/2005

Therapy/Procedure

4Mechanical Ventilators (Ventilator)
01/2011 - 05/2009
3Heterologous Transplantation (Xenotransplantation)
01/2015 - 08/2010
2Analgesia
08/2015 - 08/2010
2Ligation
10/2010 - 04/2005
1Perioperative Period
08/2015
1Artificial Respiration (Mechanical Ventilation)
01/2011
1Intravenous Injections
01/2011